Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Virology|March 18, 2016
Detection of Broadly Neutralizing Activity within the First Months of HIV-1 InfectionV Sanchez-Merino, A Fabra-Garcia, N Gonzalez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997-2015): a prospective cohort studyD Nicolás, J Ambrosioni, E de Lazzari, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2019
Performance of differential time to positivity as a routine diagnostic test for catheter-related bloodstream infections: a single-centre experienceJ Orihuela-Martín, O Rodríguez-Núñez, L Morata, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 8, 2022
Risk scores' performance and their impact on operative decision-making in left-sided endocarditis: a cohort studyA Fernández-Cisneros, M Hernández-Meneses, J Llopis, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 6, 2021
Real-life use of remdesivir in hospitalized patients with COVID-19C Garcia-Vidal, F Meira, A Cózar-Llistó, et al.
Infectious Diseases and Therapy|June 29, 2022
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 PandemicE Ariza-Vioque, F Ello, H Andriamamonjisoa, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 13, 2021
Experience with the use of siltuximab in patients with SARS-CoV-2 infectionF Meira, L Albiach, C Carbonell, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 8, 2021
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infectionE Moreno-García, E Rico, L Albiach, et al.
Pageof 3